Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...

Knowable Magazine reports on a new blood test, myLuma, predicting postpartum depression risk with over 80% accuracy, aiding ...

Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks as she imagined that something bad was going to happen to her baby, and ...

SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...

The test is intended for patients with moderate to severe depression and differentiates between unipolar and bipolar depression.

A world-first study has shown that it is possible to determine who is likely to get depression in late-life based on a "genetic score." The longitudinal study of more than 12,000 people over 70 paves ...

Antidepressant choice or strategy may not alter overall cognition in older adults with treatment-resistant depression, but ...

Deep within the brain, scientists have pinpointed a cluster of cells whose overactivity can spark anxiety, depression, and social withdrawal. By restoring balance in this small but powerful region, ...